ArticleBlood cancer journal2017

Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib.

E Kastritis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.